UT HEALTH EAST TEXAS SPECIALTY HOSPI — History
CCN 452051 | 3-year financial timeline | COVID resilience: 0/100
🛡️ Public data only — no PHI permitted on this instance.
$10M
Latest Revenue (FY2022)
-16.9%
Revenue CAGR (3yr)
-18.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $14M | $12M | $10M | -17.6% | -16.9% |
| Operating Expenses | $13M | $15M | $12M | -20.8% | -7.0% |
| Operating Margin | 5.4% | -23.2% | -18.5% | +20.4% | +0.0% |
| Net Income | $1M | $-3M | $-2M | +34.4% | +0.0% |
| Licensed Beds | 30 | 24 | 18 | -25.0% | -22.5% |
| Total Patient Days | 8,155 | 6,257 | 5,732 | -8.4% | -16.2% |
| Medicare Day % | 46% | 41% | 41% | -1.9% | -6.4% |
| Medicaid Day % | 3% | 0% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 0/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -30.9% ($14M → $10M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-16.9%
This Hospital
+7.6%
State Avg
Latest Margin
-18.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $8M | -30.4% |
| FY2024 (proj) | $5M | -42.3% |
| FY2025 (proj) | $3M | -54.2% |